Igene Biotechnology, Inc. (IGNE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT

Igene Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2009FY 2008FY 2007FY 2006FY 20052001 - 2005
Period Ending
Jul '25 Dec '09 Dec '08 Dec '07 Dec '06 Dec '05 2001 - 2005
0161135
Upgrade
Market Cap Growth
-0.67%2257.03%-53.47%-56.63%-28.35%-61.48%
Upgrade
Enterprise Value
-14991415
Upgrade
Last Close Price
0.000.010.010.010.030.04
Upgrade
PS Ratio
0.333.940.090.62--
Upgrade
PB Ratio
0.00-6.24-0.27-0.10-0.27-0.30
Upgrade
P/FCF Ratio
--1.381.3732801.1215.79
Upgrade
P/OCF Ratio
--0.941.0932801.1215.79
Upgrade
EV/Sales Ratio
-3.431.143.95--
Upgrade
EV/EBITDA Ratio
-65.84-113.47--
Upgrade
EV/EBIT Ratio
-550.99-134.50--
Upgrade
EV/FCF Ratio
--18.128.72138336.5251.98
Upgrade
Debt / Equity Ratio
-0.08-0.14-0.14-0.56-0.52-0.68
Upgrade
Debt / EBITDA Ratio
-1.77-99.15--
Upgrade
Debt / FCF Ratio
--0.747.6264243.3335.73
Upgrade
Asset Turnover
0.000.730.800.35--
Upgrade
Inventory Turnover
--1.22---
Upgrade
Quick Ratio
1.152.320.890.470.020.17
Upgrade
Current Ratio
1.152.351.741.500.040.19
Upgrade
Return on Assets (ROA)
-8.21%0.28%-14.27%0.64%-125.71%-13.26%
Upgrade
Return on Capital Employed (ROCE)
-0.80%-1.30%--
Upgrade
Earnings Yield
-151685.81%-0.90%-602.84%-133.49%-74.14%-44.51%
Upgrade
FCF Yield
-106413.93%-1.72%72.42%72.78%0.00%6.33%
Upgrade
Buyback Yield / Dilution
-24.87%-722.18%-70.53%-1.19%-4.84%-7.01%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.